The systemic influence of platelet-derived growth factors on bone marrow mesenchymal stem cells in fracture patients

[1]  Q. Tan,et al.  The application of autologous platelet‑rich plasma gel in cartilage regeneration. , 2014, Molecular medicine reports.

[2]  I. Andia,et al.  Partnership between platelet-rich plasma and mesenchymal stem cells: in vitro experience. , 2014, Muscles, ligaments and tendons journal.

[3]  J. Wang.  Can PRP effectively treat injured tendons? , 2014, Muscles, ligaments and tendons journal.

[4]  T. Einhorn,et al.  Skeletal trauma generates systemic BMP2 activation that is temporally related to the mobilization of CD73+ cells , 2013, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[5]  P. Hernigou,et al.  Benefits of small volume and small syringe for bone marrow aspirations of mesenchymal stem cells , 2013, International Orthopaedics.

[6]  I. Bruns,et al.  PDGFRα and CD51 mark human Nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion , 2013, The Journal of experimental medicine.

[7]  H. Northoff,et al.  Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells , 2013, BMC Medicine.

[8]  P. Giannoudis,et al.  Release of growth factors and the effect of age, sex, and severity of injury after long bone fracture , 2013, Acta orthopaedica.

[9]  P. Lehenkari,et al.  Cell Surface Structures Influence Lung Clearance Rate of Systemically Infused Mesenchymal Stromal Cells , 2013, Stem cells.

[10]  B. Gharibi,et al.  Effects of Medium Supplements on Proliferation, Differentiation Potential, and In Vitro Expansion of Mesenchymal Stem Cells , 2012, Stem cells translational medicine.

[11]  Karina Dahl Steffensen,et al.  Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab , 2012, Journal of Ovarian Research.

[12]  P. Giannoudis,et al.  Transcriptional profile of native CD271+ multipotential stromal cells: evidence for multiple fates, with prominent osteogenic and Wnt pathway signaling activity. , 2012, Arthritis and rheumatism.

[13]  A. Ignatius,et al.  Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components , 2012, Cytotherapy.

[14]  P. Giannoudis,et al.  Single-platform quality control assay to quantify multipotential stromal cells in bone marrow aspirates prior to bulk manufacture or direct therapeutic use. , 2012, Cytotherapy.

[15]  C. Voermans,et al.  The composition of the mesenchymal stromal cell compartment in human bone marrow changes during development and aging , 2012, Haematologica.

[16]  P. Giannoudis,et al.  High abundance of CD271+ multipotential stromal cells (MSCs) in intramedullary cavities of long bones , 2012, Bone.

[17]  A. Caplan,et al.  PDGF in bone formation and regeneration: New insights into a novel mechanism involving MSCs , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[18]  Thomas A Einhorn,et al.  The biology of fracture healing. , 2011, Injury.

[19]  M. Ehinger,et al.  CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. , 2011, Blood.

[20]  Hiromu Ito,et al.  Chemokines in mesenchymal stem cell therapy for bone repair: a novel concept of recruiting mesenchymal stem cells and the possible cell sources , 2011, Modern rheumatology.

[21]  P. Giannoudis,et al.  The Effect of Bone Morphogenetic Protein-2, Bone Morphogenetic Protein-7, Parathyroid Hormone, and Platelet-Derived Growth Factor on the Proliferation and Osteogenic Differentiation of Mesenchymal Stem Cells Derived From Osteoporotic Bone , 2010, Journal of orthopaedic trauma.

[22]  A. Miyawaki,et al.  Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow , 2009, The Journal of experimental medicine.

[23]  J. Richardson,et al.  Decreased osteogenesis, increased cell senescence and elevated Dickkopf-1 secretion in human fracture non union stromal cells. , 2009, Bone.

[24]  Anna Spagnoli,et al.  Regenerative Effects of Transplanted Mesenchymal Stem Cells in Fracture Healing , 2009, Stem cells.

[25]  E. Schwarz,et al.  Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. , 2009, Arthritis and rheumatism.

[26]  C. Choong,et al.  PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. , 2008, Blood.

[27]  P. Emery,et al.  Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level. , 2008, Arthritis and rheumatism.

[28]  S. Lynch,et al.  Recombinant human platelet-derived growth factor: biology and clinical applications. , 2008, The Journal of bone and joint surgery. American volume.

[29]  E. Jones,et al.  Human bone marrow mesenchymal stem cells in vivo. , 2007, Rheumatology.

[30]  N. Boiret-Dupré,et al.  Mesenchymal content of fresh bone marrow: a proposed quality control method for cell therapy , 2007, British journal of haematology.

[31]  A. Leet,et al.  Circulating Connective Tissue Precursors: Extreme Rarity in Humans and Chondrogenic Potential in Guinea Pigs , 2007, Stem cells.

[32]  L. Kanz,et al.  Novel Markers for the Prospective Isolation of Human MSC , 2007, Annals of the New York Academy of Sciences.

[33]  I. Marzi,et al.  Number and Proliferative Capacity of Human Mesenchymal Stem Cells Are Modulated Positively in Multiple Trauma Patients and Negatively in Atrophic Nonunions , 2007, Calcified Tissue International.

[34]  A. Lucia,et al.  Mobilisation of mesenchymal cells into blood in response to skeletal muscle injury , 2006, British Journal of Sports Medicine.

[35]  S. Bossi,et al.  Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine. , 2006, Transplantation proceedings.

[36]  T. Einhorn.  The Science of Fracture Healing , 2005, Journal of orthopaedic trauma.

[37]  M. Keel,et al.  Pathophysiology of polytrauma. , 2005, Injury.

[38]  Thomas A Einhorn,et al.  Fracture healing as a post‐natal developmental process: Molecular, spatial, and temporal aspects of its regulation , 2003, Journal of cellular biochemistry.

[39]  Paul Emery,et al.  Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. , 2002, Arthritis and rheumatism.

[40]  S. Sauerland,et al.  Association between injury pattern of patients with multiple injuries and circulating levels of soluble tumor necrosis factor receptors, interleukin-6 and interleukin-10, and polymorphonuclear neutrophil elastase. , 2002, The Journal of trauma.

[41]  K. Satomura,et al.  Circulating Skeletal Stem Cells , 2001, The Journal of cell biology.

[42]  L. Kinzl,et al.  Is interleukin 6 an early marker of injury severity following major trauma in humans? , 2000, Archives of surgery.

[43]  A. Freemont,et al.  Platelet-derived growth factor expression in normally healing human fractures. , 1995, Bone.

[44]  S. Gronthos,et al.  The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. , 1995, Blood.

[45]  R. Ross,et al.  Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human platelets. , 1990, Biochemistry.

[46]  H. Sinzinger,et al.  Platelet Half-Life, Plasma Thromboxane B2 and Circulating Endothelial-Cells in Peripheral Vascular Disease , 1986, Angiology.

[47]  W. Haddon,et al.  The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. , 1974, The Journal of trauma.

[48]  M. Najar,et al.  In vivo production of mesenchymal stromal cells after injection of autologous platelet-rich plasma activated by recombinant human soluble tissue factor in the bone marrow of healthy volunteers. , 2014, Tissue engineering. Part A.

[49]  M. Mastrogiacomo,et al.  A platelet-rich plasma-based membrane as a periosteal substitute with enhanced osteogenic and angiogenic properties: a new concept for bone repair. , 2013, Tissue engineering. Part A.

[50]  C. Choong,et al.  MSCs into adipogenic, chondrogenic, and osteogenic lineages identify markers and signaling pathways important in differentiation of growth of mesenchymal stem cells (MSCs): transcriptional profiling can , and FGF signaling is important for differentiation and β PDGF, TGF- , 2013 .

[51]  M. Clark,et al.  Kumar & Clark's clinical medicine , 2012 .

[52]  Hung Li,et al.  Homing genes, cell therapy and stroke. , 2006, Frontiers in bioscience : a journal and virtual library.